Real-world experience with a novel biodegradable polymer sirolimus-eluting stent: twelve-month results of the BIOFLOW-III registry

被引：37

作者：

Waltenberger, Johannes ^{[1
]}

Brachmann, Johannes ^{[2
]}

van der Heyden, Jan ^{[3
]}

Richardt, Gert ^{[4
]}

Froebert, Ole ^{[5
]}

Seige, Markus ^{[6
]}

Erglis, Andrejs ^{[7
]}

Dewilde, Willem ^{[8
]}

Winkens, Mark ^{[8
]}

Hegeler-Molkewehrum, Christian ^{[9
]}

Klein, Norbert ^{[10
]}

Hoffmannn, Stefan ^{[11
]}

机构：

[1] Univ Klinikum Munster, Dept Cardiovasc Med, Albert Schweitzer Campus 1,Gebeiude A1, D-48149 Munster, Germany

[2] Klinikum Coburg, Med Klin 2, Coburg, Germany

[3] St Antonius Hosp, Dept Cardiol, Nieuwegein, Netherlands

[4] Herzzentrum Segeberger Kliniken GmbH, Dept Cardiol & Angiol, Bad Segeberg, Germany

[5] Univ Sjukhuset Orebro, Dept Cardiol, Orebro, Sweden

[6] Krankenhaus Martha Maria gGmbH, Med Klin 1, Halle, Germany

[7] Univ Latvia, Paul Stradins Clin Univ Hosp, Latvian Ctr Cardiol, Riga, Latvia

[8] Twee Steden Hosp Tilburg, Dept Cardiol, Tilburg, Netherlands

[9] Kardiol Angiol Praxis Hegeler, Bremen, Germany

[10] Univ Leipzig, Dept Cardiol, D-04109 Leipzig, Germany

[11] Vivantes Klinikum Friedrichshain, Dept Internal Med & Cardiol, Berlin, Germany

来源：

EUROINTERVENTION | 2016年 / 11卷 / 10期

关键词：

biodegradable polymer; bioresorbable stent; coronary artery disease; drug-eluting stent; PLLA; sirolimus; NON-INFERIORITY TRIAL;

D O I：

10.4244/EIJY15M03_08

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Aims: We aimed to assess the safety and performance of a novel sirolimus-eluting stent with biodegradable polymer under real-world conditions. Methods and results: This prospective, multicentre, observational, all-corners registry enrolled 1,356 patients. The primary endpoint was target lesion failure at 12 months: it occurred in 5.1% (95% CI: 4.0-6.4) of patients in the overall population and in 7.7% (95% CI: 5.5-10.9), 5.8% (95% CI: 4.2-8.1), 1.8% (95% CI: 0.2-11.8) and 7.2% (95% CI: 5.1-10.0) of patients with diabetes mellitus, small vessels, chronic total occlusion and acute myocardial infarction, respectively. Conclusions: This novel stent platform demonstrated good clinical outcomes in an all-corners population, even in predefined high-risk groups. ClinialTrials.gov identifier: NCT01553526

引用

页码：1106 / 1110

页数：5

共 50 条

[21] Real-World Clinical Performance of a Novolimus-Eluting Stent Versus a Sirolimus-Eluting Stent
Chang, Chun-Chin
Sung, Wei-Ting
Lu, Ya-Wen
Chuang, Ming-Ju
Lee, Yin-Hao
Tsai, Yi-Lin
Chou, Ruey-Hsing
Huang, Shao-Sung
Huang, Po-Hsun
CLINICAL CARDIOLOGY, 2024, 47 (07)
[22] Real world use of ultra-thin sirolimus-eluting stent with biodegradable polymers. 9-month results from the FLEX-registry.
Lemos, Pedro A.
Chandwani, Prakash
Saxena, Sudheer
Ramachandran, Padma Kumar
Marchini, Julio F.
Galon, Micheli Z.
Abhyankar, Atul
Verma, Puneet
Sandhu, Manjinder Singh
Parikh, Nikhil
Bhupali, Ashok N.
Jain, Sharad
Prajapati, Jayesh
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (15) : B197 - B198
[23] Comparison of the Ultrathin Strut, Biodegradable Polymer Sirolimus-eluting Stent With a Durable Polymer Everolimus-eluting Stent in a Chinese Population: The Randomized BIOFLOW VI Trial
Li, Chongjian
Yang, Yuejin
Han, Yaling
Song, Dan
Xu, Jing
Guan, Changdong
Gao, Runlin
Garcia-Garcia, Hector M.
Waksman, Ron
Xu, Bo
CLINICAL THERAPEUTICS, 2020, 42 (04) : 649 - +
[24] Subacute stent thrombosis after successful placement of sirolimus-eluting coronary stents: Real-world experience
Jeremias, A
Bridges, J
Bigelow, B
Sylvia, B
Ho, KK
Pinto, DS
Cohen, DJ
Cutlip, DE
Carrozza, JP
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 98A - 98A
[25] Effectiveness of a novel biodegradable polymer, sirolimus-eluting stent platform in percutaneous coronary intervention
Dominici, Marcello
Arrivi, Alessio
Bazzucchi, Marco
De Paolis, Marcella
Milici, Caterina
Bock, Carlo
Placanica, Attilio
Lazzari, Ludovico
Diletti, Roberto
Boschetti, Enrico
MINERVA CARDIOANGIOLOGICA, 2016, 64 (01): : 1 - 8
[26] Real-world registry of the durable Angiolite fluoroacrylate polymer-based sirolimus-eluting stent: the EPIC02 RANGO study
Perez de Prado, Armando
Ocaranza-Sanchez, Raymundo
Lozano Ruiz-Poveda, Fernando
Moreu Burgos, Jose
Alvarez Ramos, Raquel
Rodrigues, Alberto
Fernandez Gonzalez, Luis
Aguar, Pablo
Garcia del Blanco, Bruno
Pinar, Eduardo
Peral, Vicente
Sainz Laso, Fermin
Ramon Rumoroso, Jose
Torres, Alfonso
Sabate, Manel
Trillo Nouche, Ramiro
REC-INTERVENTIONAL CARDIOLOGY, 2021, 3 (04): : 258 - 266
[27] The Firehawk Stent: A Review of a Novel Abluminal Groove-Filled Biodegradable Polymer Sirolimus-Eluting Stent
Saito, Yuichi
Grubman, Daniel
Cristea, Ecaterina
Lansky, Alexandra
CARDIOLOGY IN REVIEW, 2020, 28 (04) : 208 - 212
[28] Predictors of Clinical Outcomes After Implantation of Novel Sirolimus-Eluting Stent in Real-World Patient Population
Dani, Sameer
Desai, Devang
Pandya, Rashmit
Parekh, Pritesh
Vasavada, Apurva
Bhalani, Nirav
Sharma, Arvind
Sheth, Chirag
Shah, Dinesh
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (13) : B281 - B281
[29] Twelve-Month Clinical Outcomes After Implantation of Long Ultrathin Sirolimus-Eluting Stents With Biodegradable Polymers in Atherosclerotic Coronary Lesions
Ajmera, Prakash
Babu, Pothineni Ramesh
Chawla, Kamal Kumar
Mantravadi, Sai Sudhakar
Jariwala, Pankaj
Vijan, Vinod
Vijan, Vikrant
Potdar, Anil
Inamdar, M. K.
Pathak, Abhijit
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 76 (17) : B115 - B115
[30] Real-World Experience with Bigfoot Unity-A Twelve-Month Retrospective Analysis
Tillman, John
Olson, Byron P.
Malone, James K.
DIABETES, 2024, 73

← 1 2 3 4 5 →